SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1SAN - FR0000120578 - Common Stock
83.04 EUR
+0.73 (+0.89%)
We assign a fundamental rating of 5 out of 10 to 1SAN. 1SAN was compared to 52 industry peers in the Pharmaceuticals industry. 1SAN scores excellent on profitability, but there are some minor concerns on its financial health. 1SAN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
1SAN had a positive operating cash flow in the past year.
1SAN had positive earnings in each of the past 5 years.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1SAN (11.05%) is better than 78.85% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, 1SAN is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
1SAN has a Return On Invested Capital of 13.84%. This is in the better half of the industry: 1SAN outperforms 69.23% of its industry peers.
1SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 13.72%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 20.35%. This is amongst the best in the industry. 1SAN outperforms 80.77% of its industry peers.
1SAN's Profit Margin has improved in the last couple of years.
The Operating Margin of 1SAN (23.59%) is comparable to the rest of the industry.
1SAN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 71.70%, 1SAN is in line with its industry, outperforming 51.92% of the companies in the same industry.
1SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1SAN is creating value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
1SAN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, 1SAN belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that 1SAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, 1SAN is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.63%
2.3 Liquidity
1SAN has a Current Ratio of 1.27. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1SAN (1.27) is worse than 61.54% of its industry peers.
1SAN has a Quick Ratio of 1.27. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
1SAN has a Quick ratio (0.94) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -5.35% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
The Revenue has been growing slightly by 2.56% in the past year.
Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 7.11% on average per year.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.11%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.93, the valuation of 1SAN can be described as very reasonable.
Based on the Price/Earnings ratio, 1SAN is valued cheaper than 84.62% of the companies in the same industry.
1SAN is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.77, the valuation of 1SAN can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 84.62% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. 1SAN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.93 | ||
| Fwd PE | 9.77 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1SAN is valued a bit cheaper than the industry average as 67.31% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SAN indicates a somewhat cheap valuation: 1SAN is cheaper than 67.31% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.03 | ||
| EV/EBITDA | 10.64 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1SAN does not grow enough to justify the current Price/Earnings ratio.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.61
PEG (5Y)2.14
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
1SAN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1SAN (12/30/2025, 7:00:00 PM)
83.04
+0.73 (+0.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap201.70B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target105.38 (26.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-3.06%
PT rev (3m)-3.98%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)0.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.93 | ||
| Fwd PE | 9.77 | ||
| P/S | 2.97 | ||
| P/FCF | 20.03 | ||
| P/OCF | 17.72 | ||
| P/B | 2.88 | ||
| P/tB | 21.7 | ||
| EV/EBITDA | 10.64 |
EPS(TTM)7.6
EY9.15%
EPS(NY)8.5
Fwd EY10.24%
FCF(TTM)4.15
FCFY4.99%
OCF(TTM)4.69
OCFY5.64%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)4.61
PEG (5Y)2.14
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / 1SAN.MI FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.
What is the valuation status of SANOFI (1SAN.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (1SAN.MI) has a profitability rating of 7 / 10.
How financially healthy is SANOFI?
The financial health rating of SANOFI (1SAN.MI) is 5 / 10.
What is the expected EPS growth for SANOFI (1SAN.MI) stock?
The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 2.37% in the next year.